BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 19, 2017
View Archived Issues
Animal model mimics social exclusion in depression
Read More
Aravax initiates clinical trials of PVX-108 to treat peanut allergy
Read More
BioAtla and Sinobioway expand CAB antibody collaboration
Read More
Pfizer initiates first-in-human study of PF-06667272
Read More
Amphivena initiates phase I trial of AMV-564 for AML
Read More
CHMP adopts negative opinion for masitinib in indolent systemic mastocytosis
Read More
FDA awards fast track designation to Sage Therapeutics' SAGE-217
Read More
Novel Zika VLP vaccine demonstrates enhanced efficacy in vivo
Read More
Albireo Pharma reveals phase III program for A-4250
Read More
ObsEva completes phase I drug-drug interaction study with OBE-022
Read More
HSV-1716 is safe and shows evidence of immune response and viral replication in phase I study
Read More
Roche divulges novel compounds for treating influenza
Read More
Esteve presents new sigma1-receptor ligands
Read More
SIWA Therapeutics provides update on SIWA-318 monoclonal antibody
Read More
Cinfa reports promising topline data on biosimilar pegfilgrastim
Read More
Noxxon signs clinical trial agreement for evaluation of NOX-A12 in combination with pembrolizumab
Read More
Pfizer's Xalkori approved for new indication in Japan
Read More
Thermo Fisher Scientific partners with Agios to develop ivosidenib companion diagnostic
Read More
Symic reports topline results from phase I/IIa study of SB-061 for osteoarthritis of the knee
Read More
Nuclear receptor ROR-gamma T inhibitor VPR-254 shows promise in colitis model
Read More
Amgen submits BLA for erenumab
Read More
FDA approves Keytruda for certain patients with locally advanced or metastatic urothelial carcinoma
Read More
mGlu5 receptor levels linked to post-traumatic stress disorder
Read More
Abide Therapeutics presents new preclinical and clinical data on ABX-1431
Read More
EMA committee hands down positive opinion on Veltassa for treatment of hyperkalemia
Read More
WHO prepares to deploy Ebola vaccine in latest outbreak
Read More